Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease

Fibroblast growth factor 21 (FGF21) is an endocrine factor that regulates glucose and lipid metabolism. Circulating FGF21 predicts cardiovascular events and mortality in type 2 diabetes mellitus, including early-stage chronic kidney disease, but its impact on clinical outcomes in end-stage renal dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohara, Marina, Masuda, Takahiro, Shiizaki, Kazuhiro, Akimoto, Tetsu, Watanabe, Yuko, Honma, Sumiko, Sekiguchi, Chuji, Miyazawa, Yasuharu, Kusano, Eiji, Kanda, Yoshinobu, Asano, Yasushi, Kuro-o, Makoto, Nagata, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459464/
https://www.ncbi.nlm.nih.gov/pubmed/28582462
http://dx.doi.org/10.1371/journal.pone.0178971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459464/
https://www.ncbi.nlm.nih.gov/pubmed/28582462
http://dx.doi.org/10.1371/journal.pone.0178971

Ejemplares similares